Zingo Powder
Product Images NDC 61388-123

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Zingo (NDC 61388-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Powder Pharmaceutical Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Carton Label)

Carton Label (Carton Label)
This text appears to contain information about a medication in powder form for intradermal injection, specifically mentioning hydrochloride monohydrate. The medication seems to be intended for single use as it contains 12 sterile units. The text also indicates the presence of a label place on the packaging. The product's expiry date is mentioned as well.*
FDA Label Image

Device Label (Device Label)

FDA Label Image

Structure Formula (Figure Lhm Structure)

FDA Label Image

Figure 1a (Figure1a)

FDA Label Image

Figure 1b (Figure1b)

Figure 1b (Figure1b)
This text is not readable.*
FDA Label Image

Figure (Figure2)

FDA Label Image

Figure 3 (Figure3)

FDA Label Image

Figure 4 (Figure4)

FDA Label Image

Figure 5a (Figure5a)

Figure 5a (Figure5a)
This text appears to refer to a product or item that may involve sealing against the skin. It is likely related to skincare, cosmetics, or medical supplies.*
FDA Label Image

Figure 5b (Figure5b)

Figure 5b (Figure5b)
This text describes the safety configuration of a button where pressing it down against the skin raises it to a position where it can be inwardly pressed with the thumb. The button can be locked and unlocked, and it is ready to be pressed inward when unlocked.*
FDA Label Image

Figure 6 (Figure6)

FDA Label Image

Table 1 (Table1)

Table 1 (Table1)
This text provides a comparison of the Visual Analogue Scale Score between an active group (N=345) and a placebo group (N=348) in an adult study. The adjusted mean Least Squares Means (LSM) for the active group is 16.23, with a difference in LSMs of 4.62 (SE 1.55) between the two groups. The 95% confidence interval for this difference ranges from 7.67 to 15.7. This information can be useful in evaluating the safety and efficacy of the study intervention.*
FDA Label Image

Table 2 (Table2)

Table 2 (Table2)
This text provides data from Table 2 displaying the Modified FACES Scale Score for Studies 1 and 2 in relation to Active and Placebo groups. The table includes Adjusted Mean LSM values, Difference in LSMs with their standard errors, and 95% Confidence Limits.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.